Skip to content

Effects of different doses of rocuronium bromide on intraoperative neuromonitoring during da Vinci robotic thyroid surgery: a prospective, randomized, controlled study

Effects of different doses of rocuronium bromide on intraoperative neuromonitoring during da Vinci robotic thyroid surgery: a prospective, randomized, controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054279
Enrollment
Unknown
Registered
2021-12-12
Start date
2021-12-13
Completion date
Unknown
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid tumor

Interventions

ROC1 group:Rocuronium Bromide 0.3mg/kg
ROC2 group:Rocuronium Bromide 0.6mg/kg
ROC3 group:Rocuronium Bromide 0.9mg/kg

Sponsors

Union Hospital Affiliated to Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Markov classification 1-2, aged 18-60 years, body mass index (BMI) 18-28kg/m^2; 2. American society of anesthesiologists (ASA) classification I-II.

Exclusion criteria

Exclusion criteria: 1. Emergency surgery patients; 2. Suffering from severe cardiovascular disease, liver and kidney insufficiency; 3. Suspected difficult airway, patients with hoarseness or recurrent laryngeal nerve injury or tumor invasion before surgery, and patients who changed the surgical method during surgery.

Design outcomes

Primary

MeasureTime frame
Neuromonitoring peaks at various time points;

Secondary

MeasureTime frame
Voice disturbance score at 1day, 10days, and 2 months after surgery;During the operation, the patient's body movement and the number of times of choking;Hemodynamic parameters during induction of anesthesia;Endotracheal intubation completion time;Endotracheal intubation cooper score;

Countries

China

Contacts

Public ContactZhang Liangcheng
13365910567@163.com+86 13365910567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026